Cybin (HELP) Interest & Investment Income (2020 - 2025)
Cybin (HELP) reported Interest & Investment Income of $689.24 for Q2 2025, down 39.76% on a YoY basis from $1144.2 in Q2 2024, and down 85.94% quarter-over-quarter from $4902.1 in Q4 2024.
Cybin (HELP) Interest & Investment Income (2020 - 2025) Analysis & Trends
Cybin has reported Interest & Investment Income for 6 years, with the latest figure at $689.24 in Q2 2025.
- For the quarter ending Q2 2025, Interest & Investment Income fell 39.76% year-over-year to $689.24; the trailing twelve-month figure through Jun 2025 stood at $689.24 (down 39.76% YoY), and the FY2025 full-year result was $6.0 million, up 1198.04% from the prior year.
- Interest & Investment Income for Q2 2025 stood at $689.24, down from $4902.1 in the prior quarter.
- The five-year high for Interest & Investment Income was $3.8 million in Q3 2024, with the low at -$13260.7 in Q4 2022.
- Historically, Interest & Investment Income has averaged $319087.7 across 5 years, with a median of $25684.7 in 2021.
- Annual changes were most pronounced in 2022 — Interest & Investment Income tumbled 110.58% — and 2024, when it soared 3671.25%.
- Cybin's Interest & Investment Income stood at $125347.1 in 2021, then tumbled by 110.58% to -$13260.7 in 2022, then jumped by 101.53% to $203.47 in 2023, then soared by 2309.31% to $4902.1 in 2024, then plunged by 85.94% to $689.24 in 2025.
- The last three Interest & Investment Income figures came in at $689.24 (Q2 2025), $4902.1 (Q4 2024), and $3.8 million (Q3 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 597,319.59 |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 40.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 305,000.00 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 103,341.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 114.80 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -14.79 Mn |
| 10 | Cybin | 75.42 Mn | 75.42 Mn | - | 689.24 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 689.24 |
| Dec 31, 2024 | 4,902.13 |
| Sep 30, 2024 | 3.83 Mn |
| Jun 30, 2024 | 1,144.23 |
| Dec 31, 2023 | 203.47 |
| Sep 30, 2023 | 101,446.54 |
| Jun 30, 2023 | 62,534.01 |
| Feb 28, 2023 | 15,574.28 |
| Dec 31, 2022 | -13,260.65 |
| Sep 30, 2022 | 228,490.38 |
| May 31, 2022 | 3,087.59 |
| Dec 31, 2021 | 125,347.10 |
| Sep 30, 2021 | 75,468.88 |
| Jun 30, 2021 | 35,795.19 |
| Dec 31, 2020 | 10,738.77 |